Browsing Tag
OTTAVA
2 posts
NYSE: JNJ Q4 earnings rise 49% to $2.10 EPS; oncology and neuroscience lead portfolio momentum
Johnson & Johnson posts $94.2B in 2025 revenue and sets $100.5B FY26 target. Find out what’s driving growth and how STELARA’s erosion could impact momentum.
Johnson & Johnson’s next-gen surgical robot OTTAVA enters operating rooms for the first time
Find out how Johnson & Johnson MedTech's OTTAVA robotic surgical system is advancing minimally invasive surgery with its first completed clinical trial cases.